alt
alt
SHARE:

Dr. Paul Drew

There is more than one path to a cure.
Dr. Paul Drew’s research helps us better understand the cells that destroy myelin and cause MS–and identify therapies that prevent further attacks.

Paul Drew, PhD, is a Professor in the Department of Neurobiology and Developmental Sciences at the University of Arkansas for Medical Sciences. After receiving his PhD in Zoology (Cell and Molecular Biology) from the University of Maryland, Dr. Drew received postdoctoral training in the Neuroimmunology Branch of the National Institute of Neurological Diseases and Stroke, National Institutes of Health (NIH). The NIH, the National Science Foundation, and private funding agencies including the National Multiple Sclerosis Society and the Rampy MS Research Foundation have steadily funded Dr. Drew’s research. Dr. Drew’s research expertise concerns modulating innate and adaptive immune responses as potential treatments for MS. His work is well published and he has been an invited speaker in a variety of national and international forums. Dr. Drew is on the editorial board of a variety of journals and plays an active role in a variety of scientific societies. He reviews grants regularly for national and international societies including the NIH and the National Multiple Sclerosis Society.

Note: For clarity, Dr. Drew does not work for the Rampy MS Research Foundation. Rather, he is a beneficiary of our Foundation’s support of the MS research being done at UAMS